BioCentury
ARTICLE | Company News

Galen, Nuvo sales and marketing update

July 15, 2013 7:00 AM UTC

Nuvo and its Zars Pharma Inc. subsidiary granted Galen's Galen U.S. Inc. subsidiary exclusive, U.S. rights to commercialize Nuvo's Synera patch. The license is for Synera's approved indication - to ...